Cogent Biosciences
$0.00 (0.00%) As of 12:52 PM UTC pre-market
Why Robinhood?
You can buy or sell COGT and other stocks, options, and ETFs commission-free!
About COGT
Cogent Biosciences, Inc. Common Stock, also called Cogent Biosciences, is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of precision therapies for genetically defined diseases.
CEO
Andrew R. Robbins
Employees
15
Headquarters
Cambridge, Massachusetts
Founded
2014
COGT Key Statistics
Market Cap
312.28M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
186.16K
High Today
$8.16
Low Today
$7.90
Open Price
$7.95
Volume
184.62K
52 Week High
$14.88
52 Week Low
$1.61
COGT Earnings
-$6.06
-$4.04
-$2.02
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 11, Pre-Market